Michael Stephen Tung - 17 Feb 2026 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
EVP & CFO
Signature
/s/ Elizabeth Keiley, as Attorney-in-fact
Issuer symbol
VTVT
Transactions as of
17 Feb 2026
Net transactions value
+$1,660,255
Form type
4
Filing time
18 Feb 2026, 16:11:09 UTC
Previous filing
21 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tung Michael Stephen EVP & CFO C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT /s/ Elizabeth Keiley, as Attorney-in-fact 18 Feb 2026 0002069755

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Employee stock option (right to buy) Award $1,660,255 +44,969 +100% $36.92 89,969 17 Feb 2026 Class A Common Stock 44,969 $36.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 25% on the first anniversary of the grant date and in quarterly equal installments thereafter.